MOH — authorised 28 May 2020
- Marketing authorisation holder: AVID RADIOPHARMS INC
- Status: likely_approved
MOH authorised Tauvid on 28 May 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 28 May 2020.
AVID RADIOPHARMS INC holds the UAE marketing authorisation.